TransMedics (TMDX) Other Accumulated Expenses (2018 - 2026)

TransMedics' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $19.7 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 42.93% year-over-year to $19.7 million in Q1 2026; TTM through Mar 2026 was $19.7 million, a 42.93% increase from a year earlier, with the FY2025 full-year figure at $18.4 million, up 90.42% from the prior year.
• Other Accumulated Expenses climbed to $19.7 million in Q1 2026 per TMDX's latest filing, from $18.4 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $19.7 million in Q1 2026 and bottomed at $2.7 million in Q1 2023.
• The 5-year median for Other Accumulated Expenses is $10.4 million (2024), against an average of $10.1 million.
• Across the five-year window, Other Accumulated Expenses plunged 41.35% in 2023 and surged 391.46% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $4.4 million in 2022, then surged by 169.56% to $11.8 million in 2023, then decreased by 18.08% to $9.6 million in 2024, then soared by 90.42% to $18.4 million in 2025, then advanced by 7.27% to $19.7 million in 2026.
• Per Business Quant, the three latest TMDX Other Accumulated Expenses figures stand at $19.7 million (Q1 2026), $18.4 million (Q4 2025), and $15.8 million (Q3 2025).